SH PHARMA(02607.HK): Zhao Yong Elected Employee Representative Director of the 9th Board of Directors

NewTimeSpace News: Shanghai Pharmaceuticals Holding Co.,Ltd (02607.HK) issued an announcement on 17 June that Mr. Zhao Yong was elected as the employee representative director of the Company’s 9th Board of Directors at the 3rd Joint Session of the 3rd Employee Representative Congress held on 16 June 2026. His term of office aligns with that of the 9th Board. Currently serving as the Company’s Deputy Party Secretary and Vice President, Mr. Zhao previously held posts including Deputy Director of Shanghai Municipal Health and Family Planning Commission. He holds no shares in the Company and receives no separate remuneration for his directorship role.

NewTimeSpace News: On 17 June 2026, Shanghai Pharmaceuticals Holding Co.,Ltd (02607.HK) released an announcement. At the 3rd Joint Session of the 3rd Employee Representative Congress convened on 16 June 2026, Mr. Zhao Yong was elected employee representative director of the Company’s 9th Board of Directors, which does not require approval by the shareholders’ general meeting. His term of office shall be consistent with the term of the 9th Board of Directors.

Born in June 1972, Mr. Zhao holds a Master of Laws from the Department of International Politics, Fudan University, and an EMBA from Cheung Kong Graduate School of Business. He currently serves as Deputy Party Secretary of the Company, employee representative director of the 8th Board of Directors, and Vice President, and concurrently acts as a director of several subsidiaries. His previous appointments include Vice President of Shanghai Lanwei Medical Laboratory, Deputy Director of Shanghai Municipal Health and Family Planning Commission, and Director of Changning District Informatization Commission of Shanghai.

As at the date of the announcement, Mr. Zhao does not hold any shares in the Company and has no other connections with the Company’s directors, senior management, major shareholders or controlling shareholder. He will not receive remuneration for discharging his duties as a director, but will receive compensation pursuant to the Company’s remuneration policy based on his internal corporate position.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.